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Abstract
This study used 16S rRNA-based pyrosequencing to examine the microbial community that is closely associated with the
colonic mucosa of five healthy individuals. Spatial heterogeneity in microbiota was measured at right colon, left colon and
rectum, and between biopsy duplicates spaced 1 cm apart. The data demonstrate that mucosal-associated microbiota is
comprised of Firmicutes (50.9%621.3%), Bacteroidetes (40.2%623.8%) and Proteobacteria (8.6%64.7%), and that
interindividual differences were apparent. Among the genera, Bacteroides, Leuconostoc and Weissella were present at
high abundance (4.6% to 41.2%) in more than 90% of the studied biopsy samples. Lactococcus, Streptococcus, Acidovorax,
Acinetobacter, Blautia, Faecalibacterium, Veillonella, and several unclassified bacterial groups were also ubiquitously present
at an abundance ,7.0% of total microbial community. With the exception of one individual, the mucosal-associated
microbiota was relatively homogeneous along the colon (average 61% Bray-Curtis similarity). However, micro-heterogeneity
was observed in biopsy duplicates within defined colonic sites for three of the individuals. A weak but significant Mantel
correlation of 0.13 was observed between the abundance of acidomucins and mucosal-associated microbiota (P-value =
0.04), indicating that the localized biochemical differences may contribute in part to the micro-heterogeneity. This study
provided a detailed insight to the baseline mucosal microbiota along the colon, and revealed the existence of micro-
heterogeneity within defined colonic sites for certain individuals.
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Introduction
As an extension of the Human Genome Project, the Human
Microbiome Project (HMP) was initiated to examine the
microorganisms that human hosts harbor. One of the important
objectives of HMP is to address the relationship between diseases
with changes in the human microbiome [1]. The working
hypothesis behind this objective is that host health status reflects
the presence or abundance of certain microbial groups, and that
these microbial groups can contribute either directly or indirectly
to disease susceptibility [1]. To illustrate, numerous recent studies
examined the gut microbiota present in various disease models:
obesity [2,3,4,5], and gastrointestinal diseases including ulcerative
colitis and colorectal cancer [6,7,8]. Although promising results
have been reported for some disease models, in particular obesity,
the correlation between health status and mutualistic microbiota
are still plagued by numerous confounding factors such as
differences in host genetics, the dietary regimen, and environ-
mental exposures. The approach of treating each person as their
individualized and internalized control overcomes these potential
confounding effects and technical challenges. This is particularly
relevant in gastrointestinal disease models, which typically involve
localized inflamed sites and adjacent healthy tissues. By compar-
atively examining mucosal-associated microbes present in both
healthy and diseased sites within the same individual, the
differences in the microbial communities can be better evaluated
for its correlation to health status. However, prior to this, it is
imperative to examine the baseline microbial diversity in each
individual, and determine how the microbial community varies
along the intestinal tract (i.e., longitudinal axis) and within sites of
close proximities (i.e. small scale biogeographical differences).
Past studies have relied on molecular-based fingerprinting
methods like denaturing gradient gel electrophoresis (DGGE)
and terminal restriction fragment length polymorphism (T-RFLP)
to examine the mucosal-associated microbiota [9,10,11]. It was
shown that the predominant bacterial phyla in mucosa biopsy
samples included Firmicutes, Bacteroidetes and Proteobacteria
[11], and the microbial community remained relatively homog-
enous throughout the intestinal tract [9,10]. However, finger-
printing methods are generally only able to identify predominant
commensal microbiota (.1% of total microbial community), and
this level of technical resolution means that DGGE and T-RFLP
may not provide a representative evaluation of the microbial
spatial distribution.
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associated microbiota by utilizing high-throughput sequencing
technology (i.e., 16S rRNA-based pyrosequencing). A total of
165,953 sequences (approximately 47416776 sequences per
sample) were obtained, and evaluated for the microbial commu-
nity that is associated with the colonic mucosa of five healthy
individuals. Besides elucidating the baseline mucosal microbiota in
these five individuals, the spatial heterogeneity in a longitudinal
axis (i.e., right colon, left colon and rectum) and between biopsy
duplicates in close proximity (i.e., spaced 1 cm apart) were also
examined in the healthy colonic mucosa.
Materials and Methods
Ethics statement
All procedures were approved by the Carle Foundation
Hospital (No. 0670) and University of Illinois (No. 07232)
Institutional Review Boards. Subjects provided written informed
consent prior to colonoscopy.
Sample collection
F i v eh e a l t h ys u b j e c t s( 2w o m e n ,b o t ho fa g e5 0 ,a n d3m e n ,o fa g e s
50, 73 and 74), undergoing routine screening colonoscopy at Carle
Foundation Hospital (Urbana, IL USA),were recruited for this study.
Two of these individuals (A and B) were spousal partners living in the
same household. Individuals were prescribed 1.9 L of an oral
polyethylene glycol (PEG) and electrolyte solution (Golytely;
Braintree Laboratories, Braintree, MA) for bowel cleansing prior to
colonoscopy. The standard prescription includes consuming 240 ml
Golytely per time over the course of 8 h on the evening before
colonoscopy. The recruited individuals also fast overnight (without
breakfast), and had not been on antibiotics for at least 30 days prior to
sample collection. After obtaining informed consent, subjects were
given opioid analgesic (IV fentanyl) and amnesiac (midazolam),
respectively, to lessen discomfort during the procedure. Four mucosa
biopsies, approximately 1 cm apart, were collected from right colon
(ascending colon), left colon (descending colon) and terminal colon
(rectum), respectively, using Boston Scientific Radial Jaw
TMJumbo
forceps (3.2 mm). Of the four biopsies taken from each site, two
adjacent biopsies of epithelial mucosa were immediately frozen in
liquid nitrogen and used for microbial analysis via 454 pyrosequenc-
ing. The remaining two biopsies were fixed in Bouin’s solution for
mucin histochemistry analysis. Fixed biopsies were sent to the Carle
Foundation Hospital Pathology Services Laboratory (Urbana, IL
USA) for processing, embedding, and sectioning. In total, 30 biopsy
samples were collected. Five pooled stool samples from a total of 20
other healthy individuals of the same age group were also collected to
provide an outgroup comparison against the colonic microbial
community. Subjects who submitted stool samples had been
informed of the stool sampling procedure. Briefly, stools were self-
collected at home by the enrolled individual, and were immediately
immersed in 100% ethanol for storage at room temperature. The
stools were then transported to laboratory within 24 h, and
immediately frozen at 220uC for storage.
Demographic information
Demographic information of the five subjects is summarized in
Table 1. In brief, all subjects had no known history of
gastrointestinal disease. However, subject C had mild diverticulosis
and a 7 mm flat adenomatous polyp in the sigmoid colon. Subject
E had diverticulosis in right colon and sigmoid colon. Endoscopic
findings confirmed that all subjects were free of gastrointestinal
diseases, and none of the mucosa tissues sampled exhibited
abnormalities. To identify acidomucins (sialomucins and sulfomu-
cins), biopsy sections were stained with high iron diamine (HID)
and alcian blue (AB), pH 2.5, as previously described [12], and
counterstained with nuclear fast red for 2 min. The stained biopsy
sections were then examined with a Zeiss Axiovert 200M
Microscope and the Mosaix module in Axiovision 4.5 software.
The Automeasure module in Axiovision 4.5 was used to select and
quantify the area of sialomucin and sulfomucin within goblet cells
based on pixel color. The scoring system was executed as
described previously [13]. In brief, the area of sialomucin and
sulfomucin within goblet cells was measured, and then normalized
to the area of epithelium containing the quantified mucin. A
scoring index (0–3) was formulated to categorize the percentage of
positive staining for sialomucin and sulfomucin, respectively
(Table 1).
DNA extraction, barcoded PCR and 454 pyrosequencing
Genomic DNA was extracted using QIAamp DNA Stool Mini
Kit (Qiagen, Valencia, CA). Modifications were made to the
Table 1. Demographic information of the five individuals.
Average score ± Standard Deviation
Sulfomucins Sialomucins
Subject Age Gender Race Endoscopic Findings RC LC RE RC LC RE
*A 50 F Caucasian Normal ileum, colon and rectum 2.260.3 2.360.8 2.160.7 1.360.6 1.160.2 2.460.5
*B 50 M Caucasian Normal ileum, colon and rectum 1.860.3 1.860.6 1.660.7 1.360.8 1.060.0 1.760.6
C 73 M Caucasian Mild diverticulosis and 7 mm flat adenomatous
polyp in sigmoid colon. Normal ileum, colon
and rectum.
1.960.2 1.760.6 1.360.5 1.560.4 2.460.8 2.760.6
D 50 F Caucasian Normal ileum, colon and rectum 1.860.8 1.860.5 1.360.5 2.161.0 1.060.0 1.360.3
E 74 M Caucasian Diverticulosis in right colon and sigmoid colon.
Otherwise normal ileum, colon and rectum.
2.060.0 2.260.8 1.860.8 1.260.4 1.860.5 1.860.5
Mucin staining was done to determine the abundance of sulfomucins and sialomucins in the epithelium. The abundance of mucin stained goblet cells was further
categorized according to a scoring index, where a score of 0 denotes no staining of that particular mucin type in epithelium, a score of 1 denotes 1–10% staining of that
particular mucin type in epithelium, a score of 2 denotes 11–50% of staining of that particular mucin type in epithelium, and a score of 3 denotes .50% staining of that
particular mucin type in epithelium. RC, LC and RE denote right colon, left colon and rectum, respectively.
*denotes spousal partners living in the same household.
doi:10.1371/journal.pone.0025042.t001
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bacteria. Briefly, samples were added with enzymatic lysis buffer,
lysozyme and achromopeptidase, and incubated at 37uC for 1 h.
Proteinase K and lysis buffer AL were then added, and the
suspension was incubated at 56uC for an additional 30 min.
Genomic DNA was then subjected to spin column purification and
elution. The concentration of extracted genomic DNA was
measured with a Qubit fluorometer (Invitrogen, Carlsbad, CA).
Samples for 454 pyrosequencing were amplified for the 16S rRNA
hyper-variable regions (V4 to V5) with universal forward 519F (59-
Fusion A-Barcode -CAGCMGCCGCGGTAATWC-39) and re-
verse 926R (59-Fusion B-Barcode- CCGTCAATTCMTT-
TRAGTT-39) primer pairs (www.roche.com). PCR reaction
mixtures comprised 1 ng of genomic DNA, 25 ml of Premix F
(Epicentre Biotechnologies, WI), 200 nM (each) of forward and
reverse primers, 0.5 U of Ex Taq DNA polymerase (Takara Bio,
Japan), and the volume added up to 50 ml with molecular-biology
grade water. PCR with 35 cycles of thermal program (denatur-
ation, 95uC for 30 s; annealing, 55uC for 45 s; and extension,
72uC for 60 s) was performed. The use of 35 thermal cycles was
determined based on preliminary Q-PCR analysis, which denoted
a threshold cycle ranging from 29–38 cycles was required to
exponentially amplify the acetogenic, sulfate-reducing and me-
thanogenic microbial populations from 1 ng of genomic DNA
(data not shown). All amplicons were gel-excised, concentrated
and purified with Wizard DNA purification kit (Promega,
Madison, WI).
Pyrotag handling and analysis
454 pyrosequencing was carried out on 454 FLX Titanium
(Roche, Switzerland). The paired-end pyrosequencing services
were provided by Roy J. Carver Biotechnology Center, University
of Illinois. A total of 165,953 16S rRNA sequences (also referred as
16S pyrotags) were obtained and sorted based on their respective
barcodes to form a total of 35 pyrotag libraries. Raw sequence
reads were checked for their quality to minimize the effects of
random sequencing errors. Briefly, quality check included the
elimination of sequences that did not perfectly match the proximal
PCR primer, and those with short sequencing length (,150 nt).
All 16S pyrotags were then removed of their primers, barcodes,
and adaptor sequences, and had an average read length of 369 nt
after trimming (Table S1). 16S pyrotags identified with reverse
orientation were also reverse complemented on RDP Pipeline
Initial Process [14]. Processed pyrotags were then aligned based on
RDP Infernal [14].
Taxonomical classification and statistical analysis
RDP Classifier (version 10.21) was used for taxonomical
assignments of the 16S pyrotags at 95% confidence level [14].
Primer-E worksheets that detailed the percentage abundances of
individual bacterial genera were collated, and subsequently
analyzed by multidimensional scaling (MDS) with Primer-E
version 5 (http://www.primer-e.com/). Bray-Curtis dissimilarity
matrix and mantel correlation analysis were calculated using
the ‘‘vegdist’’ function in the Vegan package 1.17-3 in R (https://
r-forge.r-project.org/projects/vegan/) on the genus-level commu-
nity matrix. In addition, RDP Lib Compare was used to estimate
the probability of observing differences in the abundance of a
given phylogenetic taxon [15].
Rarefaction curves and identification of shared OTUs
Aligned sequences for each sample were generated with their
individual cluster files based on the RDP pyrosequencing pipeline.
The cluster files were in turn used to generate rarefaction curves
that defined the number of operational taxonomic units (OTUs,
identified at 97% sequence similarity level) with respect to the total
number of pyrotags read (Figure S1A). Regression analysis was
also performed with Sigma Plot to fit the rarefaction curves into
double rectangular hyperbola curve models (Table S2). Based on
the regression curves, the number of OTUs identified based on
4000 pyrotags were noted for comparison of microbial richness
(Figure S1B). A combined cluster file that includes all the mucosal-
associated pyrotag libraries was also generated. Dereplication at
97% gene similarity level was performed to determine the unique
OTUs present in all the mucosal-associated pyrotag libraries [14].
Given the relatively small number of individuals in our study
(n=5), a more stringent criteria was imposed when defining the
ubiquitous bacterial groups. A Perl script was used to sort the
OTUs that were shared by (i) .90% of the 30 biopsy samples, and
(ii) were present in at least one of biopsy duplicates retrieved at a
particular colonic site of the individual. The OTUs were blasted
for their identity on RDP and then clustered into their respective
bacterial groups.
Results
Interindividual differences in the abundance of mucosal-
associated microbiota
Both mucosal-associated and stool microbiota were comprised
of three main phyla: Firmicutes, Bacteroidetes and Proteobacteria.
All three phyla were consistently present, albeit at varying
abundances in different individuals (Figure 1). Interindividual
differences were apparent in the mucosal-associated microbiota
(Bray-Curtis dissimilarity = 0.5060.11, Figure S2), and the
proportion of Bacteroidetes with respect to Firmicutes varied
among the individuals studied. For example, Firmicutes were
present in individual A at abundances ranging from 28.8% to
80.8% of total microbial community, while the abundance of
Bacteroidetes in the mucosa of this individual ranged from 3.4 to
63.9% of total microbial community. Individual E also harbored
significantly higher proportions (.21-fold) of Firmicutes compared
to Bacteroidetes in the right colon and rectal mucosa (Figure 1). In
contrast, individual B had a higher abundance of Bacteroidetes
(56.9 to 78.4% of total microbial community) in all of the sampled
biopsies compared to the Firmicutes (19.0 to 38.7% of total
microbial community). Besides Firmicutes and Bacteroidetes, the
abundance of Proteobacteria (1.7% to 19.2% of total microbial
community) also varied inter-individually, but was generally much
lower in abundance compared to Firmicutes and Bacteroidetes
(Figure 1). The three predominant phyla were mainly comprised
of bacterial classes Bacilli (35.2%), Clostridia (14.4%), Bacteroidia
(40.3%), Betaproteobacteria (2.3%) and Gammaproteobacteria
(5.8%). In addition, unclassified Bacteria and the phylum
Actinobacteria were also present in low abundance (,1% of total
microbial community) in all of the examined biopsy samples. Rare
phyla, namely Cyanobacteria, Fusobacteria, Acidobacteria, Ver-
rucomicrobia, Chloroflexi, TM7, Nitrospira, Lentisphaerae,
Synergistetes, Planctomycetes, Deinococcus-Thermus and Gem-
matimonadetes, sporadically occurred at low abundance (approx-
imately 0.1% of total microbial community) in some individuals
(data not shown).
Bacterial groups present in .90% of studied biopsy
samples
Ubiquitous bacterial groups that were present in .90% of the
30 studied biopsy samples were further evaluated and identified
based on the consensus model OTU sequences (Material S1).
These bacterial groups were also present in at least one of the
16S Pyrosequencing of Mucosal Microbiota
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individual. The genus Bacteroides and lactic acid bacteria Leuconostoc
and Weissella were present at high abundance in all individuals,
ranging from 15.3% to 41.2%, 4.6% to 18.8%, and 6.4% to
24.1% of total microbial community, respectively (Table 2).
Besides Leuconostoc and Weissella, other lactic acid bacteria
including Lactococcus and Streptococcus were also present at an
average abundance ranging from 0.23% to 6.4% of total microbial
community. The bacterial genera that were ubiquitously present
also consisted of the genera Acidovorax, Acinetobacter, Blautia,
Faecalibacterium, Veillonella, and several unclassified bacterial groups,
although these latter genera were present at relatively lower
abundance than Bacteroides and the lactic acid bacteria (Table 2).
Differences in mucosal-associated microbiota along the
colon
Distinct differences in the taxonomical profiles of mucosal-
associated microbiota and pooled stool microbiota resulted in two
groups that clustered apart on the multidimensional scaling plot
(MDS) regardless of the host origins (Figure 2), suggesting that the
mucosal-associated microbiota examined in this study were not
contaminated with feces. Within an individual, the mucosal-
associated microbiota in the rectum, left and right colon clustered
separately in the MDS (Figure 2). Further evaluation of the Bray-
Curtis dissimilarity index along the colon showed relative
homogeneity in the mucosal-associated microbiota. On average,
the Bray-Curtis dissimilarity index obtained for all individuals was
0.3960.05 (i.e., 61% similarity) in mucosal-associated microbiota
along the colon, although the extent of dissimilarity differed
among individuals (Figure 3A). To illustrate, mucosal-associated
microbiota of individuals B and C was on average 0.2560.05
dissimilar (i.e., sharing 75% similarity) along the different sites of
colon. In the three remaining individuals, the Bray-Curtis
dissimilarities ranged from 0.44 to 0.55 (i.e., ,56% similarity),
indicating a relatively higher extent of heterogeneity in mucosal-
associated microbiota along the colon for these three individuals.
One-way ANOVA was carried out to determine if the Bray-Curtis
dissimilarity among the sampling sites of each individual varied
significantly. With the exception of individual E who harbored
Figure 1. Bacterial phyla in colonic biopsy samples of five individuals and stool pool. Firmicutes, Bacteroidetes and Proteobacteria
represent the three predominant phyla, and their respective abundance was listed accordingly. Y-axis denotes relative percentage abundance with
respect to total Bacteria. Abbreviations RC-1, LC-1 and RE-1 denote biopsy duplicate 1 from right colon, left colon and rectum, respectively.
Abbreviations RC-2, LC-2 and RE-2 denote biopsy duplicate 2 from right colon, left colon and rectum, respectively. Abbreviations S-1 to S-5 denotes
the five pooled stool samples.
doi:10.1371/journal.pone.0025042.g001
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ota along the colon (P-value = 0.01), the other four individuals did
not have significant differences in their Bray-Curtis dissimilarity
among sampling sites (P-values . 0.35).
Micro-heterogeneity among biopsy duplicates of some
individuals
We further evaluated if heterogeneity existed in biopsy
duplicates obtained at the same colonic location but spaced 1
cm apart. Given that the five studied individuals exhibited an
average of 0.39 Bray-Curtis dissimilarity along the colon, we used
the 0.39 index as a benchmark to elucidate the differences among
duplicate biopsies. The data indicated that the Bray-Curtis
dissimilarity index exhibited between biopsy duplicates at the
same colonic location was lower than 0.39 for most individuals
(Figure 3B), indicating that heterogeneity in mucosal-associated
microbiota at small biogeographical distances was lower than that
in the longitudinal direction. However, there were three
exceptions, namely, between right colon duplicates in individual
A (Bray-Curtis dissimilarity index = 0.40), between rectal
duplicates in individual C (Bray-Curtis dissimilarity index =
0.43), and between left colon duplicates in individual D (Bray-
Curtis dissimilarity index = 0.58). In addition, the biopsy
duplicates retrieved from the right colon of individual A and the
left colon of individual D exhibited a 1.6-fold and 2.3-fold
difference in the microbial richness (defined as number of OTUs
at 97% sequence similarity), respectively (Figure S1B).
Correlation between acidomucin staining and the
microbial community
We attempted to determine if micro-heterogeneity in the
localized mucosal-associated microbiota would correlate to
localized biochemical differences. Based on the acidomucin
staining, interindividual differences in the abundance of sialomu-
cins and sulfomucins were apparent (Table 1). Unlike the
microbial community, which exhibited no observable clustering
differences in relation to the colonic site (Figure 2), the abundance
of acidomucins (i.e., combination of both sialo- and sulfomucins) in
the rectum generally clustered together and apart from those in
the left and right colon (Figure S3). We further examined the
correlation between the abundance of acidomucins goblet cells
and the microbial community, and observed a weak but significant
correlation between the two parameters (Mantel correlation =
0.13, P-value = 0.04).
Discussion
The mucosa is the anatomical site at which the host first
encounters gut microorganisms [16], and it plays a key role in
intestinal homeostasis [17,18,19]. We inferred that microorgan-
isms that are associated with the colonic mucosa would play a
significant role in the modulation of host health, and are worthy of
a closer examination. To date, our understanding of mucosal-
associated microbiota has been derived primarily from culture-
based analysis as well as from earlier studies utilizing microbial
profiling methods (e.g., DGGE and T-RFLP) [20]. A limited
number of deep sequencing studies have been conducted to
elucidate the phylogenetic identities of colonic mucosal-associated
microbes, in particular, the microbiota from healthy individuals
(Table 3). This study therefore utilized 16S rRNA-based
pyrosequencing technology to provide a comprehensive insight
to the baseline microbial community that is closely associated with
the colonic mucosa.
It is interesting to note that two of the five individuals in this
study were spousal partners living in the same household. Yet, the
Table 2. Bacterial groups that were ubiquitously present in the mucosa of the five individuals.
Phylogenetic affiliations
Average percent abundance with respect to total microbial community ± standard deviation across the
three sampled sites in the same individual
ABCDE
Firmicutes
Blautia 0.1660.05 0.1660.05 0.5060.16 0.5360.29 0.2760.24
Faecalibacterium 0.9960.85 1.3160.39 0.3860.15 0.8960.47 0.4360.54
Lactococcus 5.5562.33 1.4060.77 3.3761.71 3.2462.98 6.3563.83
Leuconostoc 15.61610.11 4.5662.23 10.3365.03 9.9868.62 18.79610.24
Streptococcus 0.6960.57 0.2360.16 0.8460.35 0.5060.46 1.4360.42
Weissella 20.64613.48 6.3563.35 13.6766.50 13.32612.11 24.12613.16
Veillonella 0.4160.38 0.1460.12 0.3860.11 0.3260.33 0.5760.32
Unclassified Clostridiales 3.7662.57 4.4260.83 6.9660.95 6.9564.25 2.8562.56
Bacteroidetes
Bacteroides 28.07620.75 26.93613.94 41.18611.60 18.3969.37 15.26621.65
Proteobacteria
Acidovorax 0.0760.07 0.0260.02 0.0960.10 0.0360.04 0.1060.10
Acinetobacter 1.8061.24 0.5460.35 1.5060.78 1.2961.46 3.3762.23
Unclassified Enterobacteriaceae 3.5260.87 0.6860.47 3.3761.25 1.3961.32 3.8161.64
Unclassified Pasteurellaceae 0.3160.33 0.6160.23 2.1960.94 0.0760.05 1.2661.61
Ubiquity was defined based on the presence of related OTUs in (i) .90% of the 30 biopsy samples, and (ii) were present in at least one of biopsy duplicates retrieved at
a particular colonic site of the individual. The OTUs were blasted for their phylogenetic affiliations on RDP. The consensus model OTU sequences can be found in
Material S1.
doi:10.1371/journal.pone.0025042.t002
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on the MDS, indicating that each host harbors a unique mucosal-
associated microbiota and that the host effect is a significant
confounder on the gut microbiota. Our data demonstrate that
despite interindividual differences, the five individuals harbored
consistently high predominance of Firmicutes (50.9%) and
Bacteroidetes (40.2%), and the abundances of both phyla closely
approximate findings from previous studies (Table 3 and Table 4).
Closer examination at a finer taxonomical resolution however
revealed slight differences in the abundance of bacterial groups
that were ubiquitously observed in the mucosa. To illustrate, this
study showed a high abundance of Bacteroides spp. and lactic-acid
bacteria (LAB) including Leuconostoc spp., Weissella spp. and
Lactococcus spp. among the five individuals. In contrast, previous
studies reported Bacteroides spp. and microbial groups belonging to
Ruminococcaceae and Lachnospiraceae to be more commonly
found in mucosa-associated microbiota (Table 3 and Table 4).
Besides interindividual differences, the variations in our findings
may also be explained by slight differences in experimental
technicalities such as sequencing depth and DNA extraction
protocols.
Regardless, because of their high abundance and persistence in
the five individuals, Bacteroides spp. and LAB are postulated to form
the keystone groups in the breakdown of carbohydrates to provide
to the metabolic needs of these five individuals. In the human
intestinal tract, Bacteroides spp. and related species hydrolyze
complex dietary polysaccharides [21,22,23], and can also degrade
endogenous secretions such as exfoliated epithelial cells and mucus
fragments as well as residual dietary polysaccharides in the distal
colon and rectum [24]. Their versatility in utilizing a broad array
of polysaccharides may account for their predominance, and
possibly, their role in sustaining the presence of other microbes in
the intestinal tract. In contrast, Leuconostoc, Weissella and Lactococcus,
primarily utilize readily fermentable sugars (e.g., hexoses and
pentoses) to produce lactic acid [25]. Given the relatively low
abundance of such simple carbohydrates in the distal colon and
rectum, the provision of substrates for LAB may depend on the
degradation of complex polysaccharides by Bacteroides spp. The
utilization of different substrates and the resulting micro-niches
may explain the inverse relationship in the abundance of Bacteroides
and LAB that was observed in the biopsy samples in close
proximity to each other (Figure S4).
Our findings further indicate that some individuals exhibited a
certain extent of micro-heterogeneity, both along the colon (i.e.,
45% similarity for individual E) and in between locations that were
1 cm apart (i.e., on average 53% similarity for biopsy duplicates
Figure 2. Multidimensional scaling plot (MDS) of bacterial lineages in the mucosal-associated and stool microbiota. Mucosal-
associated microbiota within individuals varied along and within the sampling sites. The mucosal-associated microbiota is distinctly clustered apart
from the stool microbiota.
doi:10.1371/journal.pone.0025042.g002
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account for the presence of micro-heterogeneity in the mucosal-
associated microbiota. For example, diverticulosis in the right
colon of individual E (Table 1) may have perturbed the localized
microbial populations, and resulted in the relatively higher micro-
heterogeneity along the colon for this individual. Alternatively,
host genetics and dietary preferences are also major factors
influencing the differentiation of gut microbiota [26,27]. In
addition, mucins (i.e., neutral mucins and acidomucins) are a
source of endogenous substrates for the mucosal-associated
bacterial fermentation, and interindividual differences in the
mucin content may therefore be a factor to explain for differences
in gut microbiota [28]. Among the mucins, acidomucins are the
predominant mucin type in the colon [29]. The presence of sulfate
and sialic acids on the carbohydrate chains of acidomucins result
in higher viscosity and acidity that may be resistant to mucosal-
associated bacterial fermentation [30]. We inferred that varying
concentration of acidomucins in an individual can in turn lead to
differences in the bioavailability of endogenous substrates, which
may correlate to the micro-heterogeneity of colonic mucosal-
associated microbiota.
To address this inference, we observed localized differences in
the abundance of acidomucin-positive goblet cells, along and
within the colon of an individual. We further found that the
abundance of acidomucin in an individual is weakly correlated
with the mucosal-associated microbiota (Mantel correlation =
0.13, P-value = 0.04). Although weak, this correlation indicates
that the micro-heterogeneity in mucosal-associated microbiota
may relate, in part, to localized variation in the biochemical
environment associated with the duplicate biopsies. This observa-
tion is in agreement with published findings, which reported that
resident mucolytic bacteria may differ among individuals accord-
ing to the specific carbohydrate composition of intestinal mucins
[31,32]. In this study, the weak correlation and relatively small
sample size did not permit a conclusive identification of the
bacterial groups that were associated with variations in the
acidomucins abundance. However, past studies have found that
sulfate-reducing bacteria (e.g., Desulfotomaculum spp. and Desulfo-
bacter spp.) were more abundant in gastrointestinal sites with
greater numbers of sulfomucin-containing goblet cells [12,13]. In
addition, Bacteroides fragilis which can cleave sulfate from
sulfomucin and in turn utilize the remaining desulfated mucins
as carbon and energy sources, is also likely to correlate to the
abundance of acidomucins [33]. Future studies involving a larger
sample size would have to be conducted to verify the occurrence of
micro-heterogeneity in colonic mucosa, as well as the potential
correlation of microbial micro-heterogeneity to localized biochem-
ical characteristics.
In recent years, comparative studies which aim to evaluate for
the role of gut microbiota in relation to gastrointestinal diseases are
increasingly common. One of the common approaches to
addressing this aim is to examine differences in the gut microbiota
of diseased and adjacent healthy mucosal samples. To access the
mucosal samples, it is necessary to perform bowel cleansing prior
colonoscopy, particularly when sampling the right and transverse
colon. The bowel cleansing preparation may have altered the
loosely adherent microbiota and the lumen microbiota, and in
turn led to underestimation of the diversity or abundance of the
Figure 3. Bray-Curtis dissimilarity indices (A) along the GI tract, and (B) within biopsy duplicates of individuals A, B, C, D and E.
Abbreviations RC, LC and RE denote right colon, left colon and rectum, respectively. * denotes that individual E exhibited significant heterogeneityi n
mucosal-associated microbiota in the three colonic sites. # denotes that biopsy duplicates at that particular colonic location was greater than the
0.39 Bray-Curtis dissimilarity index.
doi:10.1371/journal.pone.0025042.g003
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ing methodologies were used for collection of all biopsy samples,
hence validating the relative differences observed in this study.
Our findings revealed that certain individuals have micro-
heterogeneity in their gut microbiota at localized colonic sites,
and this micro-heterogeneity may potentially confound subsequent
comparative analysis. To overcome these issues, it is likely that
multiple biopsy duplicate pairs would have to be sampled at each
particular colonic site, alongside the stool samples from the same
individual, to better evaluate the extent to which dysbiosis affects
host health status.
In summary, our examination with 16S rRNA-based pyrose-
quencing provided insight into the mucosal-associated microbiota
in five healthy individuals. The data further emphasize that each
individual is unique in their abundance of particular microbial
taxa, and that micro-heterogeneity is in part due to localized
biochemical differences, which may exist in some host individuals.
Supporting Information
Figure S1 Rarefaction curves and microbial richness.
(A) Rarefaction curves of mucosal-associated microbiota obtained
from left colon (LC), right colon (RC) and rectum (RE) of
Individual A, Individual B, Individual C, Individual D, and
Individual E. At each sampling site, two biopsy samples were
retrieved and denoted as 1 and 2, respectively. Rarefaction curves
of stool microbiota from pooled stools were also shown. (B)
Microbial richness of mucosal-associated microbiota in individuals
A to E, and in the stool microbiota. Microbial richness was defined
as the number of operational taxonomic units (OTUs) identified at
97% 16S rRNA gene similarity, and based upon 4000 pyrotags.
(PDF)
Figure S2 Heat map illustrating the presence of pre-
dominant bacterial groups with relative abundance
.1% of total microbial community. Columns 1 and 2
denote the microbiota present in both left colon biopsy duplicates.
Columns 3 and 4 denote the microbiota present in both right
colon biopsy duplicates. Columns 5 and 6 denote the microbiota
present in both rectum biopsy duplicates. Columns 7 to 11 denote
the stool microbiota.
(PDF)
Figure S3 Multidimensional scaling plot (MDS) of
abundance of acidomucins (i.e. combination of sialo-
and sulfomucins) in the biopsy samples of individuals A
to E. Compared to the left and right colon biopsies, the
abundance of acidomucins in rectal biopsies were generally more
similar and clustered closer in the MDS (shown within the dotted
oval).
(TIF)
Figure S4 Heat plot illustrating the abundance differ-
ence in the bacterial groups of biopsy duplicates in
Individual A (A.Biopsy-1 and A.Biopsy-2), Individual C
(C.Biopsy-1 and C.Biopsy-2) and Individual D (D.Biopsy-1 and
D.Biopsy-2).
(TIF)
Table S1 Number of 16S pyrotags obtained for each
sample. Abbreviations RC, LC, and RE denote right colon, left
colon and rectum, respectively.
(DOC)
Table S2 Regression analyses of rarefaction curves.
Double hyperbola curve model was chosen to describe the
trajectory of the rarefaction curves. The number of OTUs (97%
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